Dynavax Technologies Corporation share price logo

Dynavax Technologies Corporation Share Price

NASDAQ: DVAX

$15.50

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 9 Feb 2026

Dynavax Technologies Corporation Stock Performance

as on February 10, 2026 at 7:59 am IST

  • Day's Low

    $15.49
    $15.50
    downward going graph

    0.06%

    Downside

  • 52 Week's Low

    52 Week's High

    $9.20
    $15.73
    downward going graph

    40.65%

    Downside

    1.48%

    Upside

    downward going graph

Dynavax Technologies Corporation share price movements today

Previous Close
$15.50
Open
$15.49
Volume
1.9M
Day's Low - High
$15.49 - $15.50
52 Week Low - High
$9.20 - $15.73

Dynavax Technologies Corporation Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Dynavax Technologies Corporation Stock Fundamentals & Key Indicators

Check Dynavax Technologies Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

Dynavax Technologies Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dynavax Technologies Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Dynavax Technologies Corporation image
Dynavax Technologies Corporation
BUY$-NANA0.00%
Regencell Bioscience Holdings Ltd image
Regencell Bioscience Holdings Ltd
NA$11.9BNANA0.00%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$23.3BNA19.1241.94%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$43.5BNA19.8815.11%
Viatris Inc. image
Viatris Inc.
HOLD$15.5B-6.89%-21.95-24.58%
See all

Analyst Recommendation on Dynavax Technologies Corporation Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Dynavax Technologies Corporation. Average target price of $22

Dynavax Technologies Corporation Share Price Target

Get share price movements and forecasts by analysts on Dynavax Technologies Corporation.

What analysts predicted

29.55%UPSIDE

Target Price

$22

Current Price

$15.5

Analyzed by

12 Analysts

Target

$22.00

Dynavax Technologies Corporation target price $22, a slight upside of 29.55% compared to current price of $15.5. According to 12 analysts rating.

Dynavax Technologies Corporation Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
60
69
55
50
73
80
72
68
95
94
Gross Profit
46
56
46
39
61
67
58
54
81
80
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
3
14
0
-8
11
17
7
-96
18
26
Net Profit Margin
5.69%
20.56%
0.39%
-17.17%
15.43%
21.82%
9.79%
-140.98%
19.62%
28.38%

Dynavax Technologies Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
4
11
0
8
35
46
439
722
232
277
Gross Profit
4
11
0
-13
15
32
265
460
182
227
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-106
-112
-95
-158
-152
-75
76
293
-6
27
Net Profit Margin
-2636.89%
-1018.24%
-29099.08%
-1938.27%
-433.29%
-161.63%
17.46%
40.56%
-2.75%
9.85%

Global Institutional Holdings in Dynavax Technologies Corporation

Funds
Holdings
Geode Capital Management, LLC
2.29%
TANG CAPITAL MANAGEMENT LLC
1.66%
Millennium Management LLC
1.38%
Chicago Capital LLC
4.46%
BlackRock Inc
14.71%
See all

Dynavax Technologies Corporation News & Key Events

  • img

    Today's Timeline - 10 February

    Tue, 04:36 PM

    -

    Dynavax's acquisition offer expired with 73.92% of shares validly tendered.

    Wed, 04:42 AM

    -

    Dynavax's DCF analysis suggests it may be overvalued by 34%, with intrinsic value at $11.56 per share.

Insights on Dynavax Technologies Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, DVAX stock has moved up by 37.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -96.09M → 26.92M (in $), with an average increase of 321.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regencell Bioscience Holdings Ltd has given 28094.3% return, outperforming this stock by 28072.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Regencell Bioscience Holdings Ltd has given 3658.5% return, outperforming this stock by 3618.2%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 95.44M → 94.87M (in $), with an average decrease of 0.6% per quarter

About Dynavax Technologies Corporation

Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company developing and commercializing vaccines to help protect against infectious diseases. The Company has two commercial products: HEPLISAV-B vaccine (Hepatitis B Vaccine (Recombinant), Adjuvanted), and CpG 1018 adjuvant. The HEPLISAV-B vaccine is used for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. HEPLISAV-B is a two-dose in-one-month adult hepatitis B vaccine. CpG 1018 adjuvant is used in HEPLISAV-B and multiple adjuvanted COVID-19 vaccines. The Company is advancing a pipeline of differentiated product candidates that leverage its CpG 1018 adjuvant to develop improved vaccines in indications with unmet medical needs. Its pipeline programs include Shingles vaccine program (Z-1018) and Plague vaccine program. Z-1018 is an investigational vaccine candidate being developed for the prevention of shingles in adults aged 50 and older.
OrganisationDynavax Technologies Corporation
E-voting on sharesClick here to vote

FAQs

What is Dynavax Technologies Corporation share price today?

Dynavax Technologies Corporation share price today is $15.5 as on at the close of the market. Dynavax Technologies Corporation share today touched a day high of $15.5 and a low of $15.49.

What is the 52 week high and 52 week low for Dynavax Technologies Corporation share?

Dynavax Technologies Corporation share touched a 52 week high of $15.73 on and a 52 week low of $9.2 on . Dynavax Technologies Corporation stock price today i.e. is closed at $15.5,which is 1.46% down from its 52 week high and 68.48% up from its 52 week low.

How to invest in Dynavax Technologies Corporation Stock (DVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dynavax Technologies Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dynavax Technologies Corporation Shares that will get you 0.0968 shares as per Dynavax Technologies Corporation share price of $15.5 per share as on February 10, 2026 at 2:29 am IST.

What is the minimum amount required to buy Dynavax Technologies Corporation Stock (DVAX) from India?

Indian investors can start investing in Dynavax Technologies Corporation (DVAX) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Dynavax Technologies Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Dynavax Technologies Corporation share’s latest price of $15.5 as on February 10, 2026 at 2:29 am IST, you will get 0.6452 shares of Dynavax Technologies Corporation. Learn more about fractional shares .